Marcie A. Goldstein
Lawyers

Filters
Grupo Supervielle S.A. ADS Offering
Davis Polk advised the joint bookrunners in connection with the international public offering by Grupo Supervielle S.A. and one of its shareholders of 20,155,453 American Depositary…
First Data $1.74 Billion Secondary Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $1.74 billion secondary offering of 97,750,000 shares of Class A…
GoDaddy Inc. $882 Million Common Stock Offering
Davis Polk advised the underwriters in connection with an $882 million public offering of GoDaddy Inc. Class A common stock.
Based in Scottsdale, Arizona, GoDaddy is a technology…
Capitol Investment Corp. IV Initial Public Offering
Davis Polk advised the joint book-running managers in connection with the initial public offering of 40,250,000 units of Capitol Investment Corp. IV, including 5,250,000 units…
BeiGene, Ltd. Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters on the $201 million public offering by BeiGene, Ltd. of American Depositary Shares. The ADSs…
Century Communities, Inc. $100 Million SEC-Registered At-The-Market Offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Century Communities, Inc. of its shares of common stock for up to an aggregate amount…
Spark Therapeutics Follow-On Offering
Davis Polk advised the representative of the underwriters in connection with the $402.5 million public offering of 5,296,053 shares of common stock of Spark Therapeutics, Inc. The…
Sienna Biopharmaceuticals Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 4,983,333 shares of common stock of Sienna Biopharmaceuticals, Inc., including shares sold pursuant to…
Kala Pharmaceuticals, Inc. Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with the $103.5 million initial public offering of common stock of Kala Pharmaceuticals, Inc. The…
Akcea Therapeutics Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 17,968,750 shares of common stock of Akcea Therapeutics, Inc., including shares sold pursuant to the…